Table 2.
IAF | Bioavailable testosterone | |||
---|---|---|---|---|
Variable | Unadjusted | Adjusted for % body fat | Unadjusted | Adjusted for % body fat |
% Body fat | 0.644*** | 0.250*** | ||
White | 0.045 | −0.115* | 0.001 | −0.057 |
Depression (CES-D) | 0.092 | 0.117* | −0.100* | −0.115* |
Smoking | 0.081 | 0.121* | 0.007 | 0.002 |
Unmarried | −0.017 | −0.032 | −0.089 | −0.103* |
Education ≤high school | 0.074 | 0.076 | 0.020 | 0.025 |
Income | −0.030 | −0.045 | 0.034 | 0.043 |
Age | 0.273*** | 0.183*** | 0.139** | 0.091 |
Framingham risk score | 0.435*** | 0.350*** | 0.205*** | 0.163*** |
Insulin resistance (HOMA-IR) | 0.514*** | 0.258*** | 0.405*** | 0.192*** |
Physical activity (KPAS) | −0.244*** | −0.117* | −0.033 | 0.026 |
Estradiol | −0.117* | −0.111* | −0.033 | −0.014 |
Testosterone | 0.088 | 0.062 | 0.623*** | 0.633*** |
SHBG | −0.460*** | −0.378*** | −0.745*** | −0.721*** |
Bioavailable testosterone | 0.420*** | 0.345*** |
CES-D, Center for Epidemiological Studies Depression Scale; HOMA-IR, homeostasis model assessment for insulin resistance; KPAS, Kaiser Physical Activity Survey.
P ≤ 0.05,
P ≤ 0.01,
P ≤ 0.001.